Kok Weng Chan Selected Research

Fatty Liver

4/2005

Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kok Weng Chan Research Topics

Disease

3	Insulin Resistance 06/2006 - 04/2005
2	Atherosclerosis 05/2005 - 02/2004
2	Hyperlipidemias (Hyperlipidemia) 04/2005 - 02/2004
1	Hypertriglyceridemia 06/2006
1	Hyperglycemia 06/2006
1	Fatty Liver 04/2005
1	Hepatomegaly 04/2005
1	Dyslipidemias (Dyslipidemia) 02/2004
1	Hypercholesterolemia 02/2004
1	Hypoadiponectinemia 02/2004

Drug/Important Bio-Agent (IBA)

3	AdiponectinIBA 06/2006 - 02/2004
2	Hormones (Hormone)IBA 05/2005 - 04/2005
1	Hypoglycemic Agents (Hypoglycemics)IBA 05/2005
1	Testosterone (Sustanon)FDA Link 05/2005
1	Angiopoietin-Like Protein 4IBA 04/2005
1	Glucose (Dextrose)FDA LinkGeneric 04/2005
1	Blood Glucose (Blood Sugar)IBA 04/2005
1	HIV Protease InhibitorsIBA 02/2004
1	Ritonavir (Norvir)FDA Link 02/2004
1	Protease Inhibitors (Protease Inhibitor)IBA 02/2004
1	CholesterolIBA 02/2004

Therapy/Procedure

1	Therapeutics 02/2004